Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 86.1 M115.8 M125.6 M — Research & development ——— — Operating income 55.6 M68.8 M36.1 M — Non-Operating Income, Total -30.8 M-3.8 M-30 M — Interest expense, net of interest capitalized 2.5 M2.6 M3.2 M — Non-Operating Income, excl. Interest Expenses -17.1 M39.2 M-5.1 M — Unusual income/expense -16.2 M-45.6 M-28.1 M — Pretax income 22.3 M-1.36 B-2.2 M — Equity in earnings 700 K300 K300 K — Taxes 9.2 M9.5 M-3.1 M — Non-controlling/minority interest 4.3 M1.8 M1.5 M — After tax other income/expense ——— — Net income before discontinued operations 8.8 M-1.37 B900 K — Discontinued operations ——— — Net income 8.8 M-1.37 B900 K — Dilution adjustment —0-1.5 M — Preferred dividends —70.9 M0 — Diluted net income available to common stockholders 8.8 M-1.44 B-600 K — Basic earnings per share (Basic EPS) 0.05-6.99-0.59 — Diluted earnings per share (Diluted EPS) 0.04-6.990 — Average basic shares outstanding 166.19 M206.06 M190.26 M — Diluted shares outstanding 205.95 M206.06 M190.26 M — EBITDA 76.4 M95.6 M63.7 M — EBIT 55.6 M68.8 M36.1 M — Cost of revenue 69.5 M73.6 M78.9 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 20.8 M26.8 M27.6 M —